Strategic Solutions to Commercial Complexity
Commercial Due Diligence for Radiopharmaceutical Investments
We provide independent, expert evaluation of radiopharmaceutical assets to determine whether they are commercially investable, operationally executable, and strategically positioned to create value.
What We Assess
Commercial Due Diligence
Market Opportunity
-
Patient population and segmentation
-
Treatment paradigm dynamics
-
Adoption drivers and barriers
Competitive Landscape
-
Current and emerging competitors
-
Differentiation and positioning
-
Clinical and commercial comparators
Commercial Feasibility
-
Site readiness and infrastructure
-
Physician adoption dynamics
-
Referral and treatment pathways
Supply Chain & Manufacturing
-
Isotope availability and scalability
-
Manufacturing constraints
-
Distribution and logistics
Pricing & Reimbursement
-
Reimbursement pathway complexity
-
Payer dynamics and coverage risk
-
Revenue sustainability
Forecast Validation
-
Bottom-up and top-down modeling
-
Sensitivity analysis
-
Key assumption stress testing
Deliverables
-
Executive diligence report
-
Investment committee-ready materials
-
Risk matrix and mitigation strategies
-
Commercial readiness scorecard
Make investment decisions with clarity and conviction
Discuss a Due Diligence Engagement.
